ORMP EBITDA | ORAMED PHARMACEUTICALS INC.

ORAMED PHARMACEUTICALS INC. (ORMP) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$2.77M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$3.66M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$2.43M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$2.49M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2012-08-31 to 2015-11-30
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$2.77M	(m)	(m)	(m)	$2.00K*	-$200.00K*	(m)	$0.00*	(m)	$23.43M
2026-03-31	Reported	(m)	-$3.66M	(m)	(m)	(m)	$5.00K	-$2.92M	(m)	$1.59M	(m)	$11.13M
2025-09-30	Reported	(m)	-$2.43M	(m)	(m)	(m)	$0.00*	-$1.63M*	(m)	$1.15M	(m)	$11.06M
2025-06-30	Reported	(m)	-$2.49M	(m)	(m)	(m)	$4.00K*	-$3.54M*	(m)	$1.03M	(m)	-$126.00K
2025-03-31	Reported	(m)	-$4.50M	(m)	(m)	(m)	$3.00K	-$3.52M	(m)	$2.21M	(m)	$584.00K
2024-09-30	Reported	(m)	-$3.09M	(m)	(m)	(m)	$5.00K*	-$7.10M*	(m)	$2.24M	(m)	$1.13M
2024-06-30	Reported	(m)	-$3.13M	(m)	(m)	(m)	$0.00*	$2.08M*	(m)	$1.44M	(m)	$1.63M
2024-03-31	Reported	(m)	-$2.96M	(m)	(m)	(m)	$2.00K	-$1.48M	(m)	$1.18M	(m)	(m)
2023-09-30	Reported	(m)	-$2.89M	(m)	(m)	(m)	$32.00K*	-$694.00K*	(m)	$957.00K	(m)	(m)
2023-06-30	Reported	(m)	-$3.79M	(m)	(m)	(m)	$20.00K*	-$2.63M*	(m)	$1.82M	(m)	(m)
2023-03-31	Reported	(m)	-$5.21M	(m)	(m)	(m)	$199.00K	-$5.55M	(m)	$4.43M	(m)	(m)
2022-09-30	Reported	(m)	-$8.19M	(m)	(m)	(m)	$121.00K*	-$2.24M*	(m)	$5.35M	(m)	$100.00K
2022-06-30	Reported	(m)	-$11.42M	(m)	(m)	(m)	$20.00K*	-$8.49M*	(m)	$9.18M	(m)	(m)
2022-03-31	Reported	(m)	-$11.25M	(m)	(m)	(m)	$47.00K	-$9.13M	(m)	$5.84M	(m)	(m)
2021-11-30	Reported	(m)	-$8.06M	(m)	(m)	(m)	(m)	-$6.90M	(m)	$6.41M	(m)	(m)
2021-09-30	Reported	(m)	-$7.49M	(m)	(m)	(m)	$18.00K*	-$5.55M*	(m)	$6.09M	(m)	(m)
2021-06-30	Reported	(m)	-$4.45M	(m)	(m)	(m)	$10.00K*	-$4.67M*	(m)	$3.20M	(m)	(m)
2021-05-31	Reported	(m)	-$6.12M	(m)	(m)	(m)	$2.00K*	-$5.64M*	(m)	$5.50M	(m)	(m)
2021-03-31	Reported	(m)	-$6.60M	(m)	(m)	(m)	$27.00K	-$3.68M	(m)	$6.17M	(m)	(m)
2021-02-28	Reported	(m)	-$4.87M	(m)	(m)	(m)	$33.00K*	-$3.25M*	(m)	$3.87M	(m)	(m)
2020-11-30	Reported	(m)	-$5.83M	(m)	(m)	(m)	$313.00K	-$6.15M	(m)	$5.77M	(m)	(m)
2020-05-31	Reported	(m)	-$2.27M	(m)	(m)	(m)	$0.00*	-$3.36M*	(m)	$1.93M	(m)	(m)
2020-02-29	Reported	(m)	-$4.04M	(m)	(m)	(m)	$0.00*	-$3.63M*	(m)	$3.32M	(m)	(m)
2019-11-30	Reported	(m)	-$2.43M	(m)	(m)	(m)	$3.00K	-$3.00M	(m)	$2.02M	(m)	(m)
2019-05-31	Reported	(m)	-$4.08M	(m)	(m)	(m)	$6.00K*	-$3.66M*	(m)	$3.86M	(m)	$0.00*
2019-02-28	Reported	(m)	-$3.57M	(m)	(m)	(m)	$0.00*	-$1.88M*	(m)	$3.11M	(m)	-$300.00K
2018-11-30	Reported	(m)	-$4.64M	(m)	(m)	(m)	$8.00K	-$4.13M	(m)	$4.35M	(m)	(m)
2018-05-31	Reported	(m)	-$4.53M	(m)	(m)	(m)	$0.00*	-$3.81M*	(m)	$4.19M	(m)	(m)
2018-02-28	Reported	(m)	-$3.11M	(m)	(m)	(m)	(m)	-$3.48M*	(m)	$2.72M	(m)	(m)
2017-11-30	Reported	(m)	-$2.73M	(m)	(m)	(m)	(m)	-$2.73M	(m)	$2.33M	(m)	(m)
2017-05-31	Reported	(m)	-$2.15M	(m)	(m)	(m)	$3.00K*	-$2.36M*	(m)	$2.27M	(m)	$0.00*
2017-02-28	Reported	(m)	-$3.37M	(m)	(m)	(m)	(m)	-$2.92M*	(m)	$3.13M	(m)	$0.00*
2016-11-30	Reported	(m)	-$2.40M	(m)	(m)	(m)	(m)	$1.50M	(m)	$2.35M	(m)	$400.00K
2016-05-31	Reported	$2.11M*	$2.11M	$1.00K*	(m)	(m)	$7.00K*	-$2.23M*	(m)	-$1.71M	(m)	(m)
2016-02-29	Reported	-$1.91M*	-$1.91M	$1.00K*	(m)	(m)	$0.00*	$2.32M*	(m)	$1.30M	(m)	(m)
2016-02-29	Reported	(m)	-$1.91M	(m)	(m)	(m)	(m)	(m)	(m)	$1.31M	(m)	(m)
2015-11-30	Reported	$2.45M	(m)	(m)	(m)	(m)	$2.00K	-$2.25M	(m)	-$1.90M	(m)	(m)
2015-05-31	Reported	-$1.63M*	-$1.63M	$1.00K*	(m)	(m)	$0.00*	-$914.00K*	(m)	$915.00K	(m)	(m)
2015-02-28	Reported	-$1.67M*	-$1.67M	$2.00K*	(m)	(m)	$0.00*	-$1.60M*	(m)	$1.14M	(m)	(m)
2014-11-30	Reported	-$1.9M	(m)	(m)	(m)	(m)	$2.00K	-$1.40M	(m)	$1.30M	(m)	(m)
2014-08-31	Reported	-$10.16M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-05-31	Reported	$1.90M*	$1.90M	$1.00K*	(m)	(m)	$3.00K*	-$1.04M*	(m)	-$1.09M	(m)	(m)
2014-02-28	Reported	-$1.19M*	-$1.19M	$1.00K*	(m)	(m)	$4.00K*	-$1.48M*	(m)	$674.00K	(m)	(m)
2013-11-30	Reported	-$1.17M	(m)	(m)	(m)	(m)	$5.00K	-$748.00K	(m)	$750.00K	(m)	(m)
2013-05-31	Reported	(m)	-$1.33M	(m)	(m)	(m)	(m)	-$1.05M*	(m)	$835.64K	(m)	(m)
2013-02-28	Reported	(m)	-$1.26M	(m)	(m)	(m)	(m)	-$1.27M*	(m)	$749.00K	(m)	(m)
2012-11-30	Reported	(m)	-$731.84K	(m)	(m)	(m)	(m)	-$792.83K	(m)	$392.63K	(m)	(m)
2012-05-31	Reported	(m)	-$540.42K	(m)	(m)	(m)	$0.00*	-$883.68K*	(m)	$249.75K	(m)	(m)
2012-02-29	Reported	(m)	-$940.35K	(m)	(m)	(m)	(m)	-$591.51K*	(m)	$710.65K	(m)	(m)
2011-11-30	Reported	(m)	-$465.92K	(m)	(m)	(m)	(m)	-$484.07K	(m)	$184.02K	(m)	(m)
2011-05-31	Reported	(m)	-$591.48K	(m)	(m)	(m)	$0.00*	-$588.30K*	(m)	$241.35K	(m)	(m)
2011-02-28	Reported	(m)	-$647.22K	(m)	(m)	(m)	(m)	-$197.05K*	(m)	$341.33K	(m)	(m)
2010-11-30	Reported	(m)	-$601.62K	(m)	(m)	(m)	(m)	-$498.36K	(m)	$286.49K	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$15.09M	(m)	(m)	(m)	$9.00K	-$9.14M	(m)	$6.38M	(m)	$11.31M
2024-12-31	Reported	(m)	-$12.78M	(m)	(m)	(m)	$18.00K	-$8.41M	(m)	$6.32M	(m)	$3.18M
2023-12-31	Reported	(m)	-$15.77M	(m)	(m)	(m)	$254.00K	-$10.29M	(m)	$8.97M	(m)	(m)
2022-12-31	Reported	(m)	-$40.60M	(m)	(m)	(m)	$496.00K	-$27.92M	(m)	$27.64M	(m)	$100.00K
2021-08-31	Reported	(m)	-$24.22M	(m)	(m)	(m)	$375.00K	-$21.18M	(m)	$20.99M	(m)	(m)
2020-08-31	Reported	(m)	-$11.76M	(m)	(m)	(m)	$82.00K	-$12.44M	(m)	$10.23M	(m)	(m)
2019-08-31	Reported	(m)	-$14.63M	(m)	(m)	(m)	$15.00K	-$12.94M	(m)	$13.52M	(m)	$300.00K
2018-08-31	Reported	(m)	-$13.53M	(m)	(m)	(m)	$5.00K	-$14.66M	(m)	$11.98M	(m)	(m)
2017-08-31	Reported	(m)	-$10.77M	(m)	(m)	(m)	$7.00K	-$5.83M	(m)	$10.28M	(m)	$400.00K
2016-08-31	Reported	(m)	-$10.01M	(m)	(m)	(m)	$9.00K	$4.66M	(m)	$7.71M	(m)	$1.33M
2015-08-31	Reported	(m)	-$7.38M	(m)	(m)	(m)	$1.00K	-$4.95M	(m)	$4.78M	(m)	-$1.00K
2014-08-31	Reported	-$5.9M	(m)	(m)	(m)	(m)	$14.00K	-$4.07M	(m)	$3.28M	(m)	$4.00K
2013-08-31	Reported	$4.31M	(m)	(m)	(m)	(m)	$6.00K	-$3.40M	(m)	-$2.27M	(m)	$205.00K
2012-08-31	Reported	-$2.87M	(m)	(m)	(m)	(m)	$2.00K	-$2.30M	(m)	$1.68M	(m)	$90.00K
2011-08-31	Reported	(m)	-$2.44M	(m)	(m)	(m)	$2.18K	-$1.71M	(m)	$1.16M	(m)	-$23.98K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Zentalis Pharmaceuticals, Inc. (ZNTL)	United States	$0.196B	-2.48
Nkarta, Inc. (NKTX)	United States	$0.205B	-1.73
Fortress Biotech, Inc. (FBIO)	United States	$0.188B	0.91
ALX ONCOLOGY HOLDINGS INC (ALXO)	United States	$0.187B	-3.52
PepGen Inc. (PEPG)	United States	$0.186B	-1.73
AN2 Therapeutics, Inc. (ANTX)	United States	$0.185B	-4.84
Foghorn Therapeutics Inc. (FHTX)	United States	$0.213B	-4.43
Organogenesis Holdings Inc. (ORGO)	United States	$0.182B	-3.70
Eledon Pharmaceuticals, Inc. (ELDN)	United States	$0.219B	-3.23
Whitehawk Therapeutics, Inc. (WHWK)	United States	$0.221B